SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):

June 2428, 2016

EVENT CARDIO GROUP INC.
(Exact name of registrant as specified in its charter)

Nevada	0-52518	20-8051714
(State or other jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

739 Colony Palm Drive

Boynton Beach, Florida

33436

(Address of principal executive offices)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 18.01 ~~Entry~~Other ~~into a Material Definitive Agreement~~Events.

On June 2428, 2016, Event Cardio Group Inc., areceived ~~Nevada~~notice that ~~corporation (~~the ~~“Company”),~~Medical ~~entered~~Device ~~into,~~Bureau ~~and~~of ~~consummated~~Health aCanada ~~share~~issued ~~exchange~~a ~~with~~Class ~~the~~2 ~~John~~medical ~~Bentivoglio Family~~device ~~Trust~~license ~~and~~for ~~the~~its ~~Frank~~NowCardio™ ~~Sgro~~heart ~~Family (2010) Trust, the shareholders of 2375757 Ontario Inc~~monitoring system., ~~pursuant~~The tolicense ~~which~~was itissued ~~acquired all~~in of the ~~outstanding~~name ~~shares~~ of ~~2375757~~Contex ~~Ontario~~International ~~Inc.~~technologies ~~for~~(Canada) ~~a total of 2,812,500 shares of the Company’s common stock. 2375757 Ontario~~ Inc. ~~had previously acquired from John Bentivoglio~~, ~~the~~an ~~Chairman~~engineering ~~and~~firm ~~Chief~~engaged ~~Executive Officer of the Company,~~by ~~rights~~Event ~~granted~~Cardio toGroup ~~him by the Company in 2014 to market and distribute the Company’s wireless cardiac monitoring device in Canada~~Inc. ~~Coupled~~(“ECGI”) ~~with the acquisition of the rights granted~~ to ~~Nicholas~~develop ~~Bozza, the Company has re-acquired all of the rights to market~~ and ~~distribute~~manufacture the ~~Company’s wireless cardiac monitoring device in Canada~~product.

~~Item~~NowCardio 3is a noninvasive continuous heart monitoring device that is both leadless and wireless, offering the functionality of Holter monitoring, event monitoring, mobile cardiac telemetry and real-time streaming of all ECG data within a single device.02 ~~Unregistered~~The ~~Sales~~NowCardio heart monitor involves a single-lead ECG patch that allows patients to be remotely monitored for extended periods of ~~Equity~~time ~~Securities~~to obtain important data which is continuously transferred to a data center for immediate analysis.

OnNowCardio ~~June~~incorporates ~~24,~~several ~~2016,~~features ~~the~~designed ~~Company issued~~to ~~2,812,500~~improve ~~shares~~patient ofadherence, ~~the~~including: ~~Company’s~~no ~~common~~wired ~~stock~~leads; towireless ~~the~~transmitter; ~~John~~automatic ~~Bentivoglio~~arrhythmia ~~Family~~detection; ~~Trust and the Frank Sgro Family (2010) Trust,~~patient-triggered inalarm; ~~exchange~~small ~~for~~footprint ~~all~~and of24/7 ~~the~~patient ~~outstanding shares of 2375757 Ontario Inc~~support. ~~The~~It ~~shares~~also ~~were~~incorporates ~~issued~~several ~~pursuant~~features designed to ~~the~~enhance ~~exemption~~diagnostic ~~from~~yield, ~~registration~~including: ~~provided~~advanced byautomated ~~Regulation~~ECG Sanalysis ~~promulgated~~software; ~~under~~superior ~~the~~noise ~~Securities~~reduction; ~~Act.~~extended ~~The~~monitoring ~~Company~~up ~~did~~to ~~not~~32 ~~pay~~days; ~~any~~real-time ~~sales~~streaming ~~commissions~~of orall ~~broker~~ECG ~~fees~~data; inmobile ~~connection~~device ~~with~~support; ~~the~~and ~~issuance~~custom ofelectrodes ~~the shares. The certificates evidencing the shares were endorsed with a legend restricting their sale or other disposition~~ without ~~compliance~~skin ~~with the registration requirements of the Securities Act or an exemption therefrom~~prep.

Item 9.01 Financial Statements and Exhibits.

Exhibit Number		Description
10.1		~~Share~~License ~~Exchange~~issued ~~Agreement~~for ~~dated~~NowCardioTM ~~June~~by ~~24,~~Health ~~2016~~Canada.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: ~~June 28~~July 5, 2016

	EVENT CARDIO GROUP INC.

	By:	/s/ John Bentivoglio
		John Bentivoglio
		Chief Executive Officer

Filing Compare · Event Cardio Group Inc.